A Remote-Directed "Virtual" Clinical Trial In Metastatic Breast Cancer To Determine Feasibility Of Evaluating Patient Response To Immunotherapy Using Spliceosome Mutational Markers (Sf3b1): The Prismm Trial (Nct04447651)
CANCER RESEARCH(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要